Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol

Objective To assess the clinical outcome of chemical synovectomy with rifampicin in hemophilic arthropathy by using the World Federation of Hemophilia (WFH) scoring system and plain radiograph. Methods We performed rifampicin synovectomy (RS) on 30 joints of 28 hemophilic patients diagnosed as hemop...

Full description

Bibliographic Details
Main Authors: Hoon Chang Suh, Don-Kyu Kim, Si Hyun Kang, Kyung Mook Seo, Hee Sang Kim, Ji Young Lee, Sang Yoon Lee, Ki Young Yoo
Format: Article
Language:English
Published: Korean Academy of Rehabilitation Medicine 2018-06-01
Series:Annals of Rehabilitation Medicine
Subjects:
Online Access:http://www.e-arm.org/upload/pdf/arm-2018-42-3-449.pdf
_version_ 1797727504010575872
author Hoon Chang Suh
Don-Kyu Kim
Si Hyun Kang
Kyung Mook Seo
Hee Sang Kim
Ji Young Lee
Sang Yoon Lee
Ki Young Yoo
author_facet Hoon Chang Suh
Don-Kyu Kim
Si Hyun Kang
Kyung Mook Seo
Hee Sang Kim
Ji Young Lee
Sang Yoon Lee
Ki Young Yoo
author_sort Hoon Chang Suh
collection DOAJ
description Objective To assess the clinical outcome of chemical synovectomy with rifampicin in hemophilic arthropathy by using the World Federation of Hemophilia (WFH) scoring system and plain radiograph. Methods We performed rifampicin synovectomy (RS) on 30 joints of 28 hemophilic patients diagnosed as hemophilic arthropathy stage I–III (based on Fernandez-Palazzi clinical classification). Clinical status (bleeding frequency, pain, joint physical status) and radiological staging were evaluated as parts of the WFH scoring system before and 1 year after RS. The patients were divided into two groups by the Arnold-Hilgartner scale of the initial X-ray as stage 3 or less for the low-stage group (n=17) and over 3 for the high-stage group (n=13). Results Total WFH joint physical scores were reduced after injection, and the number of bleeding episodes and pain showed especially significant improvement. For other subscores of the WFH joint physical score, only swelling, range of motion, and crepitus showed statistically significant improvement. According to the severity of the radiologic finding, the WFH joint physical score of both the low-stage and high-stage groups showed significant improvement. In the radiological aspect, the low-stage group, without joint space narrowing at the initial plain radiograph, showed no further aggravation after injection. However, in the high-stage group, radiology found aggravation regardless of the procedure. Conclusion It is suggested that chemical synovectomy with rifampicin may prevent hemarthrosis and improve clinical symptoms. Especially in the early stage of arthropathy without joint-space narrowing, it seems to have an additional benefit that delays radiological aggravation and preserves joint status.
first_indexed 2024-03-12T11:00:40Z
format Article
id doaj.art-8a6f37ab54ee4a98b5ce05218fe40a37
institution Directory Open Access Journal
issn 2234-0645
2234-0653
language English
last_indexed 2024-03-12T11:00:40Z
publishDate 2018-06-01
publisher Korean Academy of Rehabilitation Medicine
record_format Article
series Annals of Rehabilitation Medicine
spelling doaj.art-8a6f37ab54ee4a98b5ce05218fe40a372023-09-02T05:44:58ZengKorean Academy of Rehabilitation MedicineAnnals of Rehabilitation Medicine2234-06452234-06532018-06-0142344945610.5535/arm.2018.42.3.4494001Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval ProtocolHoon Chang Suh0Don-Kyu Kim1Si Hyun Kang2Kyung Mook Seo3Hee Sang Kim4Ji Young Lee5Sang Yoon Lee6Ki Young Yoo7 Department of Physical Medicine and Rehabilitation, Chung-Ang University, College of Medicine, Seoul, Korea Department of Physical Medicine and Rehabilitation, Chung-Ang University, College of Medicine, Seoul, Korea Department of Physical Medicine and Rehabilitation, Chung-Ang University, College of Medicine, Seoul, Korea Department of Physical Medicine and Rehabilitation, Chung-Ang University, College of Medicine, Seoul, Korea Department of Physical Medicine and Rehabilitation, Chung-Ang University, College of Medicine, Seoul, Korea Department of Physical Medicine and Rehabilitation, Chung-Ang University, College of Medicine, Seoul, Korea Department of Rehabilitation Medicine, Seoul National University Boramae Medical Center, Seoul, Korea Korea Hemophilia Foundation, Seoul, KoreaObjective To assess the clinical outcome of chemical synovectomy with rifampicin in hemophilic arthropathy by using the World Federation of Hemophilia (WFH) scoring system and plain radiograph. Methods We performed rifampicin synovectomy (RS) on 30 joints of 28 hemophilic patients diagnosed as hemophilic arthropathy stage I–III (based on Fernandez-Palazzi clinical classification). Clinical status (bleeding frequency, pain, joint physical status) and radiological staging were evaluated as parts of the WFH scoring system before and 1 year after RS. The patients were divided into two groups by the Arnold-Hilgartner scale of the initial X-ray as stage 3 or less for the low-stage group (n=17) and over 3 for the high-stage group (n=13). Results Total WFH joint physical scores were reduced after injection, and the number of bleeding episodes and pain showed especially significant improvement. For other subscores of the WFH joint physical score, only swelling, range of motion, and crepitus showed statistically significant improvement. According to the severity of the radiologic finding, the WFH joint physical score of both the low-stage and high-stage groups showed significant improvement. In the radiological aspect, the low-stage group, without joint space narrowing at the initial plain radiograph, showed no further aggravation after injection. However, in the high-stage group, radiology found aggravation regardless of the procedure. Conclusion It is suggested that chemical synovectomy with rifampicin may prevent hemarthrosis and improve clinical symptoms. Especially in the early stage of arthropathy without joint-space narrowing, it seems to have an additional benefit that delays radiological aggravation and preserves joint status.http://www.e-arm.org/upload/pdf/arm-2018-42-3-449.pdfHemophiliaArthropathyRifampicinSynovectomy
spellingShingle Hoon Chang Suh
Don-Kyu Kim
Si Hyun Kang
Kyung Mook Seo
Hee Sang Kim
Ji Young Lee
Sang Yoon Lee
Ki Young Yoo
Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol
Annals of Rehabilitation Medicine
Hemophilia
Arthropathy
Rifampicin
Synovectomy
title Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol
title_full Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol
title_fullStr Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol
title_full_unstemmed Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol
title_short Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol
title_sort clinical and radiological evaluation after chemical synovectomy with rifampicin in hemophilic arthropathy korean experience with a 2 week interval protocol
topic Hemophilia
Arthropathy
Rifampicin
Synovectomy
url http://www.e-arm.org/upload/pdf/arm-2018-42-3-449.pdf
work_keys_str_mv AT hoonchangsuh clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol
AT donkyukim clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol
AT sihyunkang clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol
AT kyungmookseo clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol
AT heesangkim clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol
AT jiyounglee clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol
AT sangyoonlee clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol
AT kiyoungyoo clinicalandradiologicalevaluationafterchemicalsynovectomywithrifampicininhemophilicarthropathykoreanexperiencewitha2weekintervalprotocol